Related Experiment Video

Updated: Jun 23, 2026

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
07:26

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis

Sharlene M Day1, Damon Duquaine, Lakshmi V Mundada

  • 1University of Michigan Medical School, Division of Cardiology, Ann Arbor, USA. sday@umich.edu

Circulation
|May 7, 2003
PubMed

Insights

Excess iron accelerates blood clot formation after arterial injury by increasing oxidative stress and impairing blood vessel function. This iron-induced vascular dysfunction may increase the risk of ischemic cardiovascular events.

Area of Science:

  • Cardiovascular Research
  • Hematology
  • Oxidative Stress Biology

Background:

  • Iron overload is linked to ischemic cardiovascular events.
  • The impact of excess iron on vascular function and thrombosis is unclear.

Purpose of the Study:

  • To investigate the effects of chronic iron loading on thrombosis, oxidative stress, and vascular reactivity in mice.
  • To elucidate the mechanisms by which iron excess influences vascular health and thrombotic responses.

Main Methods:

  • Mice received chronic iron dextran administration over 6 weeks.
  • Thrombosis was assessed after photochemical carotid artery injury.
  • Systemic and vascular oxidative stress, and endothelium-dependent vasoreactivity were measured.

Main Results:

  • Iron-loaded mice exhibited accelerated thrombus formation (20.4 min vs. 54.5 min).
  • Iron loading increased systemic and vascular reactive oxygen species production.
  • Endothelium-dependent vasorelaxation was impaired, indicating reduced nitric oxide bioavailability.

Conclusions:

  • Moderate iron loading accelerates thrombus formation and increases vascular oxidative stress.
  • Iron-induced vascular dysfunction contributes to ischemic cardiovascular events.
  • Iron overload poses a risk factor for cardiovascular complications.
Abstract

More Related Videos

Ferric Chloride-induced Murine Thrombosis Models10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...